“Safety Assessment of Dose-Escalated 225Ac-PSMA-617 Radioligand Therapy in Patients With Advanced Metastatic Castration-Resistant Prostate Cancer Following Standard Treatment Failure”. 2025. Voprosy Onkologii 71 (5): OF-2520. https://doi.org/10.37469/0507-3758-2025-71-5-OF-2520.